Patent · US Active

Compounds for the treatment of neuromuscular disorders

US10385028B2 · kind B2 · utility

3Cited by
8References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 14, 2017
Grant dateAug 20, 2019
Priority date
Expiry dateDec 14, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D333/16
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds suitable for treating, ameliorating and/or preventing neuromuscular disorders, including the reversal of drug-induced neuromuscular blockade. The compounds as defined herein preferably inhibit the CIC-1 ion channel.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.